GB2490840B - Liquid ibuprofen/codeine pharmaceutical composition for oral administration, the method for preparation thereof and use thereof - Google Patents

Liquid ibuprofen/codeine pharmaceutical composition for oral administration, the method for preparation thereof and use thereof

Info

Publication number
GB2490840B
GB2490840B GB1215436.5A GB201215436A GB2490840B GB 2490840 B GB2490840 B GB 2490840B GB 201215436 A GB201215436 A GB 201215436A GB 2490840 B GB2490840 B GB 2490840B
Authority
GB
United Kingdom
Prior art keywords
codeine
preparation
pharmaceutical composition
oral administration
liquid ibuprofen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB1215436.5A
Other versions
GB201215436D0 (en
GB2490840A (en
Inventor
Maria Jiménez Redondo Ana
Munoz Ruiz Angel
Sanz Menéndez Nuria
Martinez-Alzamora Garcia Femando
Gomez Calvo Antonia
Hernandez Herrero Gonzalo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Farmalider SA
Original Assignee
Farmalider SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmalider SA filed Critical Farmalider SA
Publication of GB201215436D0 publication Critical patent/GB201215436D0/en
Publication of GB2490840A publication Critical patent/GB2490840A/en
Application granted granted Critical
Publication of GB2490840B publication Critical patent/GB2490840B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB1215436.5A 2010-03-01 2010-03-01 Liquid ibuprofen/codeine pharmaceutical composition for oral administration, the method for preparation thereof and use thereof Expired - Fee Related GB2490840B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/ES2010/000078 WO2011107617A1 (en) 2010-03-01 2010-03-01 Liquid ibuprofen/codeine pharmaceutical composition for oral administration, the method for preparation thereof and use thereof

Publications (3)

Publication Number Publication Date
GB201215436D0 GB201215436D0 (en) 2012-10-17
GB2490840A GB2490840A (en) 2012-11-14
GB2490840B true GB2490840B (en) 2017-06-07

Family

ID=44541670

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1215436.5A Expired - Fee Related GB2490840B (en) 2010-03-01 2010-03-01 Liquid ibuprofen/codeine pharmaceutical composition for oral administration, the method for preparation thereof and use thereof

Country Status (2)

Country Link
GB (1) GB2490840B (en)
WO (1) WO2011107617A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3005262A1 (en) * 2013-05-02 2014-11-07 Philippe Gorny NOVEL PHARMACEUTICAL OR DIETETIC COMPOSITIONS FOR TOTALLY MASKING AMERTUME OF HIGH-DOSE ARGININE SALTS, IN LIQUID OR SEMI-LIQUID FORM.

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0388125A1 (en) * 1989-03-14 1990-09-19 Beecham Group Plc Medicament
CA2030140A1 (en) * 1989-11-17 1991-05-18 Manfred Lohner Medicament preparations containing a metal salt of ibuprofen and process for preparing same
US5164398A (en) * 1991-04-01 1992-11-17 Merck & Co., Inc. Ibuprofen-antitussive combinations
WO1995007103A1 (en) * 1993-09-07 1995-03-16 The Procter & Gamble Company Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
EP1226831A1 (en) * 2001-01-30 2002-07-31 Leandro Baiocchi Aqueous pharmaceutical solutions with trisubstituted glycyrrhizic acid salts

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0388125A1 (en) * 1989-03-14 1990-09-19 Beecham Group Plc Medicament
CA2030140A1 (en) * 1989-11-17 1991-05-18 Manfred Lohner Medicament preparations containing a metal salt of ibuprofen and process for preparing same
US5164398A (en) * 1991-04-01 1992-11-17 Merck & Co., Inc. Ibuprofen-antitussive combinations
WO1995007103A1 (en) * 1993-09-07 1995-03-16 The Procter & Gamble Company Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
EP1226831A1 (en) * 2001-01-30 2002-07-31 Leandro Baiocchi Aqueous pharmaceutical solutions with trisubstituted glycyrrhizic acid salts

Also Published As

Publication number Publication date
GB201215436D0 (en) 2012-10-17
WO2011107617A1 (en) 2011-09-09
GB2490840A (en) 2012-11-14

Similar Documents

Publication Publication Date Title
IL208832A (en) 3-aminocarbazole compounds, pharmaceutical compositions containing them, preparation methods thereof and use thereof in the production of drugs
IL223783B (en) Substituted 1-indole compound for use in the treatment of a disease or condition, a pharmaceutical composition comprising the compound and use of the compound for the preparation of a medicament
ZA201300100B (en) Indolizine derivatives,process for the preparation thereof and therapeutic use thereof
PT2655375E (en) Pyrimidinone derivatives, preparation thereof and pharmaceutical use thereof
ZA201209739B (en) Levocarrimycin,pharmaceutical compositions,preparation methods and uses thereof
IL222578A0 (en) Method for preparing pharmaceutical compositions intended for oral administration comprising one or more active ingredients and the compositions comprising same
IL214420A0 (en) Pharmaceutical compositions comprising tamsulosin and solifenacin for oral administration
HK1183228A1 (en) Methods and compositions for oral pharmaceutical therapy
HK1171696A1 (en) Complex formulation for oral administration comprising probiotic formulation and 5-ht4 receptor agonist and method for the preparation thereof 5-ht4
EP2263637A4 (en) Medicinal preparation for oral administration
EP2786982A4 (en) Amino-propylene-glycol derivatives, preparation method and pharmaceutical composition and use thereof
EP2560614A4 (en) Pharmaceutical compositions and methods for administering the same
EP2279731A4 (en) Improved pharmaceutical composition containing ibuprofen and codeine
ZA201209674B (en) Pharmaceutical compositions comprising paracetamol and process for preparing the same
EP2704570A4 (en) Drug substances, pharmeceutical compositions and methods for preparing the same
HU1000299D0 (en) Nanostructured atorvastatin, its pharmaceutically acceptable salts and pharmaceutical compositions containing them and process for their preparation
PL2714042T3 (en) An analgesic pharmaceutical composition for oral administration
GB2490840B (en) Liquid ibuprofen/codeine pharmaceutical composition for oral administration, the method for preparation thereof and use thereof
HU0900482D0 (en) Pharmaceutical formulation for oral administration
EP2565180A4 (en) Alpha-arylmethoxyacrylate derivative, preparation method thereof, and pharmaceutical composition containing same
EP2529755A4 (en) Pharmaceutical composition and preparation for oral administration
HK1207969A1 (en) Pharmaceutical composition for oral administration with improved dissolution and or absorption
EP2554164A4 (en) Pharmaceutical formulation based on ibuprofen and codeine having having improved stability
PL2736496T3 (en) Pharmaceutical composition containing an antimuscarinic agent and method for the preparation thereof
HU0900378D0 (en) Nanoparticulate ibuprofen compositions, process for the preparation thereof and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
789A Request for publication of translation (sect. 89(a)/1977)

Ref document number: 2011107617

Country of ref document: WO

789A Request for publication of translation (sect. 89(a)/1977)

Ref document number: 2011107617

Country of ref document: WO

PCNP Patent ceased through non-payment of renewal fee

Effective date: 20220301